Release Date: 06/08/10 15:00 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 29.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%